SSA
MBOT icon

Schonfeld Strategic Advisors’s Microbot Medical MBOT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,100
Closed -$41.2K – 2842
2026
Q1 		$41.2K Buy
+17,100
New +$38.2K ﹤0.01% 1996

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Schonfeld Strategic Advisors's MBOT Position: Q2 2026 in Review

Schonfeld Strategic Advisors sold out of Microbot Medical (MBOT) in Q2 2026, closing a stake of 17,100 shares — an estimated $41.2K sold.

Schonfeld Strategic Advisors first reported a position in MBOT in Q1 2026 and held it in 1 quarter. The position peaked at $41.2K in Q1 2026. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Schonfeld Strategic Advisors reported no remaining Microbot Medical position as of Q2 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 17,100 Microbot Medical shares in Q2 2026, an estimated $41.2K.
  • Schonfeld Strategic Advisors first reported a position in Microbot Medical in Q1 2026 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Microbot Medical position peaked at $41.2K in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.